I agree that this site is using cookies. You can find further informations here.
X
Luycx, Odile
16  results:
Search for persons X
?
1

Treatment emergent peripheral neuropathy in the CASSIOPEIA ..:

Fokkema, Cathelijne ; Moreau, Phillipe ; Van der Holt, Bronno...
Haematologica.  107 (2022)  7 - p. 1726-1730 , 2022
Link: https://doi.org/10.3324/..
 
?
2

CD200 expression in flow cytometry helps to distinguish man..:

Debord, Camille ; Robillard, Nelly ; Theisen, Olivier...
Hematological Oncology.  36 (2018)  3 - p. 607-609 , 2018
Link: https://doi.org/10.1002/..
 
?
3

Switches of tyrosine‐kinase inhibitors in chronic phase of ..:

Norwood, James ; Pastoret, Cédric ; Luycx, Odile...
American Journal of Hematology.  93 (2018)  10 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
4

Undetectable molecular residual disease after omacetaxine a..:

Coude, Marie‐Magdelaine ; Luycx, Odile ; Cariou, Marie‐Estelle...
British Journal of Haematology.  157 (2012)  3 - p. 407-410 , 2012
Link: https://doi.org/10.1111/..
 
?
5

Treatment emergent peripheral neuropathy in the CASSIOPEIA ..:

Fokkema, Cathelijne ; Moreau, Phillipe ; van der Holt, Bronno...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244836/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Emergence and evolution of TP53 mutations are a key feature..:

Lodé, Laurence ; Ménard, Audrey ; Flet, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2017.181404.  , 2018
Link: https://inserm.hal.scien..
 
?
7

Emergence and evolution of TP53 mutations are a key feature..:

Lodé, Laurence ; Ménard, Audrey ; Flet, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2017.181404.  , 2018
Link: https://inserm.hal.scien..
 
?
8

Emergence and evolution of TP53 mutations are a key feature..:

Lodé, Laurence ; Ménard, Audrey ; Flet, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2017.181404.  , 2018
Link: https://www.hal.inserm.f..
 
?
9

Emergence and evolution of TP53 mutations are a key feature..:

Lodé, Laurence ; Ménard, Audrey ; Flet, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2017.181404.  , 2018
Link: https://inserm.hal.scien..
 
?
10

Emergence and evolution of TP53 mutations are key features ..:

Lodé, Laurence ; Ménard, Audrey ; Flet, Laurent...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865441/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
11

Emergence and evolution of TP53 mutations are a key feature..:

Lodé, Laurence ; Ménard, Audrey ; Flet, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2017.181404.  , 2018
Link: https://inserm.hal.scien..
 
?
12

Emergence and evolution of TP53 mutations are a key feature..:

Lodé, Laurence ; Ménard, Audrey ; Flet, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2017.181404.  , 2018
Link: https://inserm.hal.scien..
 
?
13

Emergence and evolution of TP53 mutations are a key feature..:

Lodé, Laurence ; Ménard, Audrey ; Flet, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2017.181404.  , 2018
Link: https://inserm.hal.scien..
 
?
14

Emergence and evolution of TP53 mutations are a key feature..:

Lodé, Laurence ; Ménard, Audrey ; Flet, Laurent...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2017.181404.  , 2018
Link: https://inserm.hal.scien..
 
?
15

Serum free light chains should be the target of response ev..:

Dejoie, Thomas ; Corre, Jill ; Caillon, Helene...
boreal:177455.  , 2016
Link: http://hdl.handle.net/20..
 
1-15